Review
Targeted therapy for metastatic NSCLC: sunvozertinib superiority and sustained lorlatinib efficacy
The review emphasizes comprehensive molecular profiling in metastatic NSCLC. Pralsetinib's benefits should be considered alongside the safety concerns noted in the source.
#lorlatinib #pralsetinib #lazertinib #amivantamab #sunvozertinib d8miq7k9f04rm.cloudfront.net